REPCF REPLICEL LIFE SCIENCES INC
- 0.002100
- 0.0000000.00%
REPLICEL LIFE SCIENCES INC News
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign private issuer (related to financial reporting)
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign private issuer (related to financial reporting)
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign private issuer (related to financial reporting)
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign private issuer (related to financial reporting)
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign private issuer (related to financial reporting)
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign private issuer (related to financial reporting)
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
REPLICEL LIFE SCIENCES INC | 20-F: FY2022 Annual Report
REPLICEL LIFE SCIENCES INC | SC 13D/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Andrew Schutte(34.53%)
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
REPLICEL LIFE SCIENCES INC | D: Filing D
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
REPLICEL LIFE SCIENCES INC | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
REPLICEL LIFE SCIENCES INC | D: Filing D
Analysis
Price Target
No Data
No Data